Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Polyamines help fix DNA damage accurately in cells.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

The DiLiCre mouse model is an effective tool for precise genome editing using light.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Analog 23 is a promising compound for prostate cancer treatment.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Recombinant keratins can form useful structures for medical applications, overcoming natural keratin limitations.

Nanochitins, especially DNCh and PNCh, effectively promote hair growth.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Classic PDRN improves wound healing quality by enhancing cell migration.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

Targeting ornithine decarboxylase can help prevent skin cancer.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Chitosan-coated nanocapsules improve minoxidil delivery for better hair regrowth.

A specific microRNA, chi-miR-30b-5p, slows down the growth of hair-related cells by affecting the CaMKIIδ gene in cashmere goats.